A Single Center Study to Evaluate the Effectiveness and Safety of SOTYKTU® (Deucravacitinib) in Combination With Enstilar® for Moderate to Severe Plaque Psoriasis
Latest Information Update: 27 Mar 2024
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary) ; Deucravacitinib (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 27 Mar 2024 New trial record